On 11 June 2026 the MHRA approved oral semaglutide, the first oral GLP-1 medicine licensed in the UK for weight loss, giving people a needle-free alternative to the weekly Wegovy injection
It is very encouraging that continued treatment for four years or so is effective in helping people to lose weight at a clinically significant level of 10% on average, said Tricia Tan, professor of metabolic medicine and endocrinology at Imperial College London
B12 helps your body convert fat and protein to provide energy to your body, says Peter Kozlowski, M.D., a functional medicine doctor in Chicago
Like I said right at the top of this article, I am willing to bet big time that huge names within the sport are cheating
These are descriptive categories, not rigid classifications, but they help set expectations
In particular, they have shown a reduction of major adverse cardiovascular events (MACE) in diabetic patients at high cardiovascular risk [23,24,25,26,27,28,29,30]